Cleci Menezes Moreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cleci Menezes Moreira has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Sebastian Loureiro Mendez
Faculty of Pharmacy Federal University of Rio Grande do Sul Porto Alegre Brazil
2 shared publications Fabricio Ocampo da Luz e Silva
2 shared publicationsMaquelen Blanco Fernandes
Federal University of Pampa, Brazil
2 shared publications- Marí Castro Santos
Department of Pharmacy, Pharmacognosy Laboratory, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
2 shared publications - Michel Mansur Machado
Universidade Federal do Pampa - Unipampa
2 shared publications Sue Elle Berro da Silva
2 shared publications
Latest Publications
- Open Access
- 3 January 2024
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2024, 1-12
Phytochemistry Profile, Antimicrobial and Antitumor Potential of the Methanolic Extract of Tabernaemontana catharinensis A DC and Eragrostis plana NEES
Natural compounds that have the potential to act as antimicrobials and antitumors are a constant search in the field of pharmacotherapy. Eragrostis plana NEES (Poaceae) is a grass with high allelopathic potential. Allelopathy is associated with compounds generated in the primary and secondary metabolism of the plant, which act to protect it from phytopathogens. Tabernaemontana catharinensis A DC (Apocynaceae), a tree in which its leaves and bark are used for the preparation of extracts and infusions that have anti-inflammatory and antinociceptive effects, is attributed to its phytochemical constitution. The objective of this study was to elucidate the phytochemical constitution, the antibacterial potential, the toxicity against immune system cells, hemolytic potential, and antitumor effect of methanolic extracts of E. plana and T. catharinensis. The phytochemical investigation was carried out using the UHPLC-QTOF MS equipment. The antibacterial activity was tested using the broth microdilution plate assay, against Gram-negative and Gram-positive strains, and cytotoxicity assays were performed on human peripheral blood mononuclear cells (PBMC) and in vitro hemolysis. Antitumor activity was performed against the colon cancer cell line (CT26). Results were expressed as mean and standard deviation and analyzed by ANOVA. was considered significant. More than 19 possible phytochemical constituents were identified for each plant, with emphasis on phenolic compounds (acids: vanillic, caffeic, and quinic) and alkaloids (alstovenine, rhyncophylline, amezepine, voacangine, and coronaridine). Both extracts showed antibacterial activity at concentrations below 500 µg/mL and were able to decrease the viability of CT26 at concentrations below 2000 µg/mL, without showing cytotoxic effect on PBMCs and in vitro hemolysis at the highest concentration tested. This is the first report of the activity of E. plana and T. catharinensis extracts against colon cancer cell line (CT26). Studies should be carried out to verify possible molecular targets involved in the antitumor effect in vivo.
- 3 January 2024
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2024, 1-12
Open AccessPhytochemistry Profile, Antimicrobial and Antitumor Potential of the Methanolic Extract of Tabernaemontana catharinensis A DC and Eragrostis plana NEES
Natural compounds that have the potential to act as antimicrobials and antitumors are a constant search in the field of pharmacotherapy. Eragrostis plana NEES (Poaceae) is a grass with high allelopathic potential. Allelopathy is associated with compounds generated in the primary and secondary metabolism of the plant, which act to protect it from phytopathogens. Tabernaemontana catharinensis A DC (Apocynaceae), a tree in which its leaves and bark are used for the preparation of extracts and infusions that have anti-inflammatory and antinociceptive effects, is attributed to its phytochemical constitution. The objective of this study was to elucidate the phytochemical constitution, the antibacterial potential, the toxicity against immune system cells, hemolytic potential, and antitumor effect of methanolic extracts of E. plana and T. catharinensis. The phytochemical investigation was carried out using the UHPLC-QTOF MS equipment. The antibacterial activity was tested using the broth microdilution plate assay, against Gram-negative and Gram-positive strains, and cytotoxicity assays were performed on human peripheral blood mononuclear cells (PBMC) and in vitro hemolysis. Antitumor activity was performed against the colon cancer cell line (CT26). Results were expressed as mean and standard deviation and analyzed by ANOVA. was considered significant. More than 19 possible phytochemical constituents were identified for each plant, with emphasis on phenolic compounds (acids: vanillic, caffeic, and quinic) and alkaloids (alstovenine, rhyncophylline, amezepine, voacangine, and coronaridine). Both extracts showed antibacterial activity at concentrations below 500 µg/mL and were able to decrease the viability of CT26 at concentrations below 2000 µg/mL, without showing cytotoxic effect on PBMCs and in vitro hemolysis at the highest concentration tested. This is the first report of the activity of E. plana and T. catharinensis extracts against colon cancer cell line (CT26). Studies should be carried out to verify possible molecular targets involved in the antitumor effect in vivo.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 67, e24230976
Bioactive Compounds from Cuphea glutinosa Cham. & Schltdl.: Promising Effects on Antihypertensive Action
Cuphea glutinosa Cham. & Schltdl. (Lythraceae) is popularly used as antimicrobial, diuretic, anti-inflammatory, and antihypertensive. This species features a great diversity of flavonoids, predominantly quercetin glycosides. This study aimed to investigate the chemical composition, and acute antihypertensive effect in vivo from C. glutinosa leaf extracts on N(G)-nitro-L-Arginine methyl ester (L-NAME) induced hypertensive rats. The leaf extraction was conducted by exhaustive maceration and infusion. The chromatographic analyses were performed by ultra-fast liquid chromatography and photodiode array detection (UFLC-PDA). The assessment of antihypertensive activity in vivo was performed through the monitoring of the hemodynamic parameters. C. glutinosa shows a predominance of quercetin glycosides, majority the miquelianin. The extracts displayed an antihypertensive effect in rats in doses of 2.5 to 50 mg/kg. These results suggest that the C. glutinosa extracts present antihypertensive potential by the presence of flavonoids and interactions among the phytoconstituents. This research demonstrates that the extracts of C. glutinosa are flavonoid-rich and ratify the folk medicine usage of C. glutinosa as hypotensive and antihypertensive agents, in order to contribute to evidence-based traditional medicines.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 67, e24230976
Open AccessBioactive Compounds from Cuphea glutinosa Cham. & Schltdl.: Promising Effects on Antihypertensive Action
Cuphea glutinosa Cham. & Schltdl. (Lythraceae) is popularly used as antimicrobial, diuretic, anti-inflammatory, and antihypertensive. This species features a great diversity of flavonoids, predominantly quercetin glycosides. This study aimed to investigate the chemical composition, and acute antihypertensive effect in vivo from C. glutinosa leaf extracts on N(G)-nitro-L-Arginine methyl ester (L-NAME) induced hypertensive rats. The leaf extraction was conducted by exhaustive maceration and infusion. The chromatographic analyses were performed by ultra-fast liquid chromatography and photodiode array detection (UFLC-PDA). The assessment of antihypertensive activity in vivo was performed through the monitoring of the hemodynamic parameters. C. glutinosa shows a predominance of quercetin glycosides, majority the miquelianin. The extracts displayed an antihypertensive effect in rats in doses of 2.5 to 50 mg/kg. These results suggest that the C. glutinosa extracts present antihypertensive potential by the presence of flavonoids and interactions among the phytoconstituents. This research demonstrates that the extracts of C. glutinosa are flavonoid-rich and ratify the folk medicine usage of C. glutinosa as hypotensive and antihypertensive agents, in order to contribute to evidence-based traditional medicines.
- Open Access
- 1 January 2021
- Published by Editora Poisson
Avaliação da saúde intestinal de escolares de Uruguaiana/RS: Uma ação com foco na saúde pública
- 1 January 2021
- Published by Editora Poisson
Open AccessAvaliação da saúde intestinal de escolares de Uruguaiana/RS: Uma ação com foco na saúde pública
- Open Access
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 55
Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
The essential oil of the leaves of Eugenia sulcata, in the Myrtaceae family, has a demonstrated antihypertensive effect, but its effects on heart muscle and its toxicity have not yet been elucidated. Little chemical or biological data are available for E. sulcata, whether emphasizing the beneficial effects or the pharmacological security of this species. This study aims to evaluate myocardial contractility and to analyze angiotensin converting enzyme (ACE) and myosin ATPase activities associated with use of this essential oil. In addition, we evaluated the immunotoxicity of E. sulcata essential oil. Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were treated daily for 30 days (10 mg/kg of oil) to evaluate the isometric force of the papillary muscle, ACE measured by fluorimetry, and myosin ATPase activities by inorganic phosphate. Lymphocyte cultures were used to evaluate cytotoxicity, DNA damage, and mutagenicity of the essential oil. The results demonstrate that the treatment did not change the cardiac contraction force and did not alter the functioning of the sarcoplasmic reticulum, extrusion of the membrane calcium, or modify the membrane calcium channels or β-adrenergic receptor activity. Tetanic contractions were potentiated in the SHR animals. Myosin ATPase activity was also increased in the SHR animals. Cardiac ACE activity was reduced in both animal strains, and the serum ACE was reduced only in the SHR animals. The essential oil did not cause cytotoxicity or mutagenicity and presented low DNA damage. Our results demonstrated that the essential oil does not change myocardial contractility and does not present relevant immunotoxicity.
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 55
Open AccessEssential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
The essential oil of the leaves of Eugenia sulcata, in the Myrtaceae family, has a demonstrated antihypertensive effect, but its effects on heart muscle and its toxicity have not yet been elucidated. Little chemical or biological data are available for E. sulcata, whether emphasizing the beneficial effects or the pharmacological security of this species. This study aims to evaluate myocardial contractility and to analyze angiotensin converting enzyme (ACE) and myosin ATPase activities associated with use of this essential oil. In addition, we evaluated the immunotoxicity of E. sulcata essential oil. Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were treated daily for 30 days (10 mg/kg of oil) to evaluate the isometric force of the papillary muscle, ACE measured by fluorimetry, and myosin ATPase activities by inorganic phosphate. Lymphocyte cultures were used to evaluate cytotoxicity, DNA damage, and mutagenicity of the essential oil. The results demonstrate that the treatment did not change the cardiac contraction force and did not alter the functioning of the sarcoplasmic reticulum, extrusion of the membrane calcium, or modify the membrane calcium channels or β-adrenergic receptor activity. Tetanic contractions were potentiated in the SHR animals. Myosin ATPase activity was also increased in the SHR animals. Cardiac ACE activity was reduced in both animal strains, and the serum ACE was reduced only in the SHR animals. The essential oil did not cause cytotoxicity or mutagenicity and presented low DNA damage. Our results demonstrated that the essential oil does not change myocardial contractility and does not present relevant immunotoxicity.
- Open Access
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 1591762
Chemical Composition and Hypotensive Effect of Campomanesia xanthocarpa
Campomanesia xanthocarpa is known in Brazil as Guabiroba and is popularly used for various diseases, such as inflammatory, renal, and digestive diseases and dyslipidemia. The aim of the study was to analyze the chemical composition and investigate the effects of aqueous extract of C. xanthocarpa on the blood pressure of normotensive rats, analyzing the possible action mechanism using experimental and in silico procedures. The extract was evaluated for total phenolic compounds and total flavonoid content. The chemical components were determined by HPLC analyses. Systolic and diastolic blood pressure and heart rate were measured with extract and drugs administration. The leaves of C. xanthocarpa presented the relevant content of phenolics and flavonoids, and we suggested the presence of chlorogenic acid, gallic acid, quercetin, and theobromine. The acute administration of aqueous extract of C. xanthocarpa has a dose‐dependent hypotensive effect in normotensive rats, suggesting that the action mechanism may be mediated through the renin‐angiotensin system by AT1 receptor blockade and sympathetic autonomic response. Docking studies showed models that indicated an interaction between chlorogenic acid and quercetin with the AT1 receptor (AT1R) active site. The findings of these docking studies suggest the potential of C. xanthocarpa constituents for use as preventive agents for blood pressure.
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 1591762
Open AccessChemical Composition and Hypotensive Effect of Campomanesia xanthocarpa
Campomanesia xanthocarpa is known in Brazil as Guabiroba and is popularly used for various diseases, such as inflammatory, renal, and digestive diseases and dyslipidemia. The aim of the study was to analyze the chemical composition and investigate the effects of aqueous extract of C. xanthocarpa on the blood pressure of normotensive rats, analyzing the possible action mechanism using experimental and in silico procedures. The extract was evaluated for total phenolic compounds and total flavonoid content. The chemical components were determined by HPLC analyses. Systolic and diastolic blood pressure and heart rate were measured with extract and drugs administration. The leaves of C. xanthocarpa presented the relevant content of phenolics and flavonoids, and we suggested the presence of chlorogenic acid, gallic acid, quercetin, and theobromine. The acute administration of aqueous extract of C. xanthocarpa has a dose‐dependent hypotensive effect in normotensive rats, suggesting that the action mechanism may be mediated through the renin‐angiotensin system by AT1 receptor blockade and sympathetic autonomic response. Docking studies showed models that indicated an interaction between chlorogenic acid and quercetin with the AT1 receptor (AT1R) active site. The findings of these docking studies suggest the potential of C. xanthocarpa constituents for use as preventive agents for blood pressure.